Van der Elst Michael, Payne Sheila, Arantzamendi Maria, Preston Nancy N, Koper Ian, Belar Alazne, Brunsch Holger, Surges Séverine M, Adile Claudio, Grassi Yasmine, Cockshott Zoe, Hasselaar Jeroen, Menten Johan
Department of Oncology, Laboratory of Experimental Radiotherapy, Katholieke Universiteit Leuven, Herestraat 49, 3000, Louvain, Belgium.
International Observatory On End of Life Care, Faculty of Health and Medicine, Lancaster University, Lancaster, LA1 4AT, UK.
BMC Palliat Care. 2024 Dec 21;23(1):295. doi: 10.1186/s12904-024-01612-2.
Palliative sedation refers to the proportional use of titrated medication which reduces consciousness with the aim of relieving refractory suffering related to physical and psychological symptoms and/or existential distress near the end of life. Palliative sedation is intended to be an end of life option that enables healthcare professionals to provide good patient care but there remains controversy on how it is used. Little is known about decision-making processes regarding this procedure. The aim of this study was to explore decision-making processes in palliative sedation based on the experiences and perceptions of relatives and healthcare professionals.
We conducted a qualitative interview study with dyads (a bereaved relative and a healthcare professional) linked to 33 deceased patient with cancer who had palliative sedation, in seven in-patient palliative care settings in five countries (Belgium, Germany, Italy, the Netherlands, and Spain). A framework analysis approach was used to analyse the data.
Two main themes are defined: 1) Decision-making about palliative sedation is a complex iterative process, 2) Decision-making is a shared process between the patient, healthcare professionals, and relatives. Decision-making about palliative sedation appears to follow an iterative process of shared information, deliberation, and decision-making. The patient and healthcare professionals are the main stakeholders, but relatives are involved and may advocate for, or delay, the decision-making process. Starting palliative sedation is reported to be an emotionally difficult decision for all parties.
As decision-making about palliative sedation is a complex and iterative process, patients, relatives and healthcare professionals need time for regular discussions. This requires a high level of engagement by healthcare professionals, that takes into account patients' wishes and needs, and helps to facilitate decision-making.
姑息性镇静是指按比例使用滴定药物以降低意识,目的是缓解临终时与身体和心理症状及/或生存困扰相关的难治性痛苦。姑息性镇静旨在成为一种临终选择,使医疗保健专业人员能够提供优质的患者护理,但在其使用方式上仍存在争议。关于该程序的决策过程知之甚少。本研究的目的是基于亲属和医疗保健专业人员的经验和看法,探讨姑息性镇静中的决策过程。
我们在五个国家(比利时、德国、意大利、荷兰和西班牙)的七个住院姑息治疗机构中,对与33例接受姑息性镇静的已故癌症患者相关的二元组(一位丧亲亲属和一位医疗保健专业人员)进行了定性访谈研究。采用框架分析方法对数据进行分析。
定义了两个主要主题:1)姑息性镇静的决策是一个复杂的迭代过程,2)决策是患者、医疗保健专业人员和亲属之间的共享过程。姑息性镇静的决策似乎遵循一个共享信息、审议和决策的迭代过程。患者和医疗保健专业人员是主要利益相关者,但亲属也参与其中,可能会推动或延迟决策过程。据报道,开始姑息性镇静对各方来说都是一个情感上艰难的决定。
由于姑息性镇静的决策是一个复杂且迭代的过程,患者、亲属和医疗保健专业人员需要时间进行定期讨论。这需要医疗保健专业人员高度参与,考虑患者的愿望和需求,并有助于促进决策。